Karyopharm Therapeutics Inc.

US$0.05As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:KPTIHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (53.11%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.21
PE TTM —
TSR TTM (99.05%)
Mkt cap US$1.245M
ROIC (437.05%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.056
2.01%
(9.69%)
Hold 12|8|2|11|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
(3.70%)
2.59%
13.19%
6.96%
Revenue$M
0.125
0.124
0.124
0.125
15.81%
9.59%
6.78%
4.45%
Peers (US$1.245M)
Cap (US$)
PE
1.303M
—
1.218M
—
1.130M
—
Capital
TTM
5Y
10Y
Leveragex
0.505
(0.052)
(0.052)
EBIT/Intx
0.244
0.144
0.148
Own earn%
171.33
59.89
43.92
Sh yield%
18.12
41.24
40.67
Owners
Insiders/Inst%
6.25
67.42
Short interest%
2.06
SBC / revenue%
0.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
19–26
$1 testx
—
Incr. ROIC%
0